Literature DB >> 17386287

Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling.

Eiko Tsuiki1, Azusa Fujikawa, Noritake Miyamura, Koki Yamada, Kazuaki Mishima, Takashi Kitaoka.   

Abstract

PURPOSE: To report visual field defects after macular hole surgery with indocyanine green (ICG)-assisted internal limiting membrane (ILM) peeling.
DESIGN: Interventional consecutive case series.
METHODS: A retrospective review of 140 eyes with macular hole after vitrectomy with ILM peeling. The group with 0.25% of ICG for ILM peeling consisted of 96 eyes. The group without ICG consisted of 44 eyes.
RESULTS: Nasal visual field defects occurred in 11 eyes, temporal visual field defects in seven eyes, and concentric visual field defects in one eye. In the group with ICG, nasal visual field defects were far higher in the left eye than in the right eye.
CONCLUSIONS: We speculate that the postoperative nasal visual field defects were caused by the enhanced toxicity of ICG resulting from the exposure to illumination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17386287     DOI: 10.1016/j.ajo.2006.10.051

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Changes in visual field defects during 10-year follow-up for indocyanine green-assisted macular hole surgery.

Authors:  Masanori Nakazawa; Hiroto Terasaki; Takehiro Yamashita; Akinori Uemura; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2016-06-07       Impact factor: 2.447

2.  Synthesis, staining properties, and biocompatibility of a new cyanine dye for ILM peeling.

Authors:  Christos Haritoglou; Marcus Kernt; Peter Laubichler; Heinz Langhals; Kirsten Eibl; Ana Varja; Sebastian Thaler; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

3.  Involvement of illumination in indocyanine green toxicity after its washout in the ex vivo rat retina.

Authors:  Kazuhiro Tokuda; Charles F Zorumski; Yukitoshi Izumi
Journal:  Retina       Date:  2009-03       Impact factor: 4.256

4.  The effect of internal limiting membrane removal and indocyanine green on the success of macular hole surgery.

Authors:  John T Thompson
Journal:  Trans Am Ophthalmol Soc       Date:  2007

5.  Inner retinal thinning after Brilliant Blue G-assisted internal limiting membrane peeling for vitreoretinal interface disorders.

Authors:  Vikas Ambiya; Abhilash Goud; Mitali Khodani; Jay Chhablani
Journal:  Int Ophthalmol       Date:  2016-06-14       Impact factor: 2.031

6.  Vital dyes increase the rigidity of the internal limiting membrane.

Authors:  C Haritoglou; S Mauell; M Benoit; R G Schumann; P B Henrich; A Wolf; A Kampik
Journal:  Eye (Lond)       Date:  2013-08-16       Impact factor: 3.775

7.  Indocyanine green-assisted internal limiting membrane peeling in macular hole surgery: a meta-analysis.

Authors:  Yan Wu; Wei Zhu; Ding Xu; Yan-Hong Li; Jun Ba; Xiao-Long Zhang; Fang Wang; Jing Yu
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Outcomes of 23-gauge pars plana vitrectomy and internal limiting membrane peeling with brilliant blue in macular hole.

Authors:  Huseyin Sanisoglu; Mehmet Sahin Sevim; Betul Aktas; Semra Sevim; Ahmet Nohutcu
Journal:  Clin Ophthalmol       Date:  2011-08-19

Review 9.  Retinal Damage Induced by Internal Limiting Membrane Removal.

Authors:  Rachel Gelman; William Stevenson; Claudia Prospero Ponce; Daniel Agarwal; John Byron Christoforidis
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

10.  Evaluation of macular retinal ganglion cell-inner plexiform layer thickness after vitrectomy with internal limiting membrane peeling for idiopathic macular holes.

Authors:  Alfonso L Sabater; Álvaro Velázquez-Villoria; Miguel A Zapata; Marta S Figueroa; Marta Suárez-Leoz; Luis Arrevola; María-Ángeles Teijeiro; Alfredo García-Layana
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.